AfterNext HealthTech Acquisition Corp Units
AFTR.U
AFTR.U was delisted on the 15th of August, 2023.
11 hedge funds and large institutions have $16.8M invested in AfterNext HealthTech Acquisition Corp Units in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
5% less capital invested
Capital invested by funds: $17.6M → $16.8M (-$816K)
15% less funds holding
Funds holding: 13 → 11 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| 1 |
Jane Street
New York
|
+$607 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$69 |
Top Sellers
AFTR.U Hedge Fund Activity: Q3 2022 in Review
11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in AfterNext HealthTech Acquisition Corp Units (AFTR.U) for Q3 2022, worth a combined $16.8M — down 4.6% from $17.6M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of AFTR.U and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Jane Street, adding an estimated $607. The largest seller was HGC Investment Management, cutting an estimated $882K.
- 11 institutional investors held AfterNext HealthTech Acquisition Corp Units (AFTR.U) as of Q3 2022, down from 13 in Q2 2022.
- Funds reported $16.8M of AfterNext HealthTech Acquisition Corp Units stock for Q3 2022, down 4.6% quarter-over-quarter.
- 0 funds opened new AfterNext HealthTech Acquisition Corp Units positions in Q3 2022 and 2 closed out, a net change of -2 holders.
- The largest AfterNext HealthTech Acquisition Corp Units buyer in Q3 2022 was Jane Street, an estimated $607 added.
- The largest AfterNext HealthTech Acquisition Corp Units seller in Q3 2022 was HGC Investment Management, an estimated $882K sold.
Based on aggregated 13F filings for Q3 2022.